Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

SARS-CoV-2 spike protein plasmid DNA vaccine CORVax

A vaccine consisting of DNA plasmids encoding the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration of the SARS-CoV-2 S protein plasmid DNA vaccine CORVax and following electroporation (EP), the DNA plasmids enter the cells and the cells produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:SARS-CoV-2 S-protein DNA vaccine CORVax
SARS-CoV-2 S-protein plasmid DNA vaccine CORVax
Code name:CORVax
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search